Skip to main content

Outcomes Statement: Reinvigorating the response to antimicrobial resistance (AMR): from aspiration to implementation

Wednesday 12 – Friday 14 February 2025 I WP3471

amr image
  1. Outcomes Statement: Reinvigorating the response to antimicrobial resistance (AMR): from aspiration to implementation
  2. Key takeaways
  3. Key areas for action: Access and appropriate use
  4. Key areas for action: Improving access to antibiotics and diagnostics through supply chain and market shaping
  5. Key areas for action: Framework to establish the Independent Panel for Evidence for Action against AMR (IPEA)
  6. Key areas for action: Raising impact of AMR with other disease areas and influencing the upcoming High Level Meeting on Non-Communicable Diseases (NCDs) to raise awareness of AMR along with leveraging resources across disease areas
  7. Key areas for action: Lack of political awareness and leadership
  8. Key areas for action: Lack of public awareness and understanding
  9. Resourcing challenges and prioritisation across the AMR response
  10. Incentives for R&D and innovation
  11. Summary of specific actions to take forward and who to contact to get involved

In association with Wellcome Trust, bioMérieux, IFPMA, GSK, MSD, BD, GSCF and PAGB

Antimicrobial Resistance (AMR) is a global health security threat, affecting the health, lives, and livelihoods of people worldwide and requiring a One Health response.

Over 18 months, Wilton Park and partners convened stakeholders across One Health in a series of dialogues to explore opportunities and challenges to reinvigorate the response to AMR.

The first three dialogues, held between April and December 2023, focused on engaging parliamentarians and decision-makers to understand how AMR can be repositioned as a political priority, and the importance of presenting clear and compelling asks to public and private sector stakeholders across human and animal health. The third dialogue informed the development of an outcomes document to support advocacy efforts ahead of the United National High-Level Meeting in September 2024, and the resulting Political Declaration on AMR.

The UN HLM was followed by an intense period of activity, including AMR meetings in Berlin at the World Health Summit (October 2024), the 4th Global High Level Ministerial Conference on AMR held in the Kingdom of Saudi Arabia (November 2024), and AMR meetings at the World Economic Forum (January 2025).

Against this backdrop, the fourth dialogue in the Wilton Park series, held in February 2025, convened key stakeholders with the goal of exploring how the community will now transition from commitments to implementation, taking a One Health approach to addressing the health, social, and economic impacts of AMR. The dialogue bought together stakeholders from public and private sectors, civil society and patient groups with representatives from high, middle and low income countries with expertise in human and animal health and the environment.

This Outcomes Statement summarises the key themes discussed, the priority commitments identified, and the actionable initiatives delegates agreed to take forward.

This document does not represent a statement of policy for Wilton Park, the Foreign, Commonwealth & Development Office (FCDO) or His Majesty’s Government.

Next

Key takeaways

Want to find out more?

Sign up to our newsletter